Literature DB >> 22001247

Autonomic involvement in Parkinson's disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers.

Maria G Cersosimo1, Eduardo E Benarroch.   

Abstract

Autonomic nervous system involvement occurs at early stages in both Parkinson's disease (PD) and incidental Lewy body disease (ILBD), and affects the sympathetic, parasympathetic, and enteric nervous systems (ENS). It has been proposed that alpha-synuclein (α-SYN) pathology in PD has a distal to proximal progression along autonomic pathways. The ENS is affected before the dorsal motor nucleus of the vagus (DMV), and distal axons of cardiac sympathetic nerves degenerate before there is loss of paravertebral sympathetic ganglion neurons. Consistent with neuropathological findings, some autonomic manifestations such as constipation or impaired cardiac uptake of norepinephrine precursors, occur at early stages of the disease even before the onset of motor symptoms. Biopsy of peripheral tissues may constitute a promising approach to detect α-SYN neuropathology in autonomic nerves and a useful early biomarker of PD.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001247     DOI: 10.1016/j.jns.2011.09.030

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  39 in total

1.  Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson's Disease Patients.

Authors:  Liancai Mu; Jingming Chen; Stanislaw Sobotka; Themba Nyirenda; Brian Benson; Fiona Gupta; Ira Sanders; Charles H Adler; John N Caviness; Holly A Shill; Marwan Sabbagh; Johan E Samanta; Lucia I Sue; Thomas G Beach
Journal:  Dysphagia       Date:  2015-06-04       Impact factor: 3.438

2.  Autonomic and electrocardiographic findings in Parkinson's disease.

Authors:  Christopher H Gibbons; David K Simon; Meilin Huang; Barbara Tilley; Michael J Aminoff; Jacquelyn L Bainbridge; Matthew Brodsky; Roy Freeman; John Goudreau; Robert W Hamill; Sheng T Luo; Carlos Singer; Aleksandar Videnovic; Ivan Bodis-Wollner; Pei S Wong
Journal:  Auton Neurosci       Date:  2017-04-14       Impact factor: 3.145

3.  Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis.

Authors:  Luca Toti; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-02       Impact factor: 4.052

4.  Irritable bowel syndrome correlates with increased risk of Parkinson's disease in Taiwan.

Authors:  Shih-Wei Lai; Kuan-Fu Liao; Cheng-Li Lin; Fung-Chang Sung
Journal:  Eur J Epidemiol       Date:  2014-01-18       Impact factor: 8.082

5.  Somatosensory symptoms in unmedicated de novo patients with idiopathic Parkinson's disease.

Authors:  Katharina A Schindlbeck; Arne Mehl; Sarah Geffe; Steffen Benik; Serdar Tütüncü; Fabian Klostermann; Frank Marzinzik
Journal:  J Neural Transm (Vienna)       Date:  2015-09-21       Impact factor: 3.575

Review 6.  The clinical approach to autonomic failure in neurological disorders.

Authors:  Eduardo E Benarroch
Journal:  Nat Rev Neurol       Date:  2014-05-27       Impact factor: 42.937

Review 7.  REM sleep behavior disorder, autonomic dysfunction and synuclein-related neurodegeneration: where do we stand?

Authors:  Giacomo Chiaro; Giovanna Calandra-Buonaura; Annagrazia Cecere; Francesco Mignani; Luisa Sambati; Giuseppe Loddo; Pietro Cortelli; Federica Provini
Journal:  Clin Auton Res       Date:  2017-09-04       Impact factor: 4.435

8.  The prion hypothesis of Parkinson's disease.

Authors:  Yaping Chu; Jeffrey H Kordower
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

9.  Cutaneous autonomic denervation in Parkinson's disease.

Authors:  Judith Navarro-Otano; Jordi Casanova-Mollà; Merche Morales; Josep Valls-Solé; Eduard Tolosa
Journal:  J Neural Transm (Vienna)       Date:  2014-12-24       Impact factor: 3.575

Review 10.  The pathology roadmap in Parkinson disease.

Authors:  D James Surmeier; David Sulzer
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.